# A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries

> **NCT02720003** · NA · COMPLETED · sponsor: **C. R. Bard** · enrollment: 148 (actual)

## Conditions studied

- Femoral Artery Stenosis
- Femoral Artery Occlusion
- Stenosis of Popliteal Arteries
- Occlusion of Popliteal Arteries

## Interventions

- **DEVICE:** LTX DCB

## Key facts

- **NCT ID:** NCT02720003
- **Lead sponsor:** C. R. Bard
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2018-10
- **Final completion:** 2020-08
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02720003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02720003, "A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02720003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*